Sutro Logo high res
  • Who We Are
    • About Sutro
    • Leadership
      • Leadership Team
      • Board of Directors
      • Scientific Advisory Board
      • Clinical Advisory Board
    • Collaborations
  • Proprietary Platform
  • Pipeline
    • Overview
    • Scientific Publications
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financials
    • Stock Data
    • Governance
    • IR Resources
  • Careers
    • The Way We Work
    • DEIB
    • Sustainability
    • Internships
    • Philanthropy
      • Employee Engagement
  • Contact Us

37th Annual Meeting Society for Immunotherapy of Cancer (SITC) 2022 – Abstracts

Events, News, Presentations

37th Annual Meeting Society for Immunotherapy of Cancer (SITC) 2022 – Abstracts Abstract Number 1103 Half-life extended, conditionally active IFNa prodrug induces tumor-selective activation and potent antitumor response     Abstract Number 1191 STRO-003 is a...

Credit Suisse 31st Annual Healthcare Conference – Presentation

Events, News, Presentations

Credit Suisse 31st Annual Healthcare Conference – Presentation...

64th American Society of Hematology Annual Meeting and Exposition – Abstract

Events, News, Presentations

64th American Society of Hematology Annual Meeting and Exposition – Abstract...

Sutro Biopharma Announces Oral Presentation at the 64th American Society of Hematology Annual Meeting and Exposition

Events, News, Presentations, Press Releases

Sutro Biopharma Announces Oral Presentation at the 64th American Society of Hematology Annual Meeting and Exposition –Results from compassionate use program highlight promising activity of STRO-002 in children with rare form of acute myeloid leukemia, that is...

Sutro Biopharma to Participate in Upcoming Investor Conferences

Events, News, Presentations, Press Releases

Sutro Biopharma to Participate in Upcoming Investor Conferences SOUTH SAN FRANCISCO, Calif., November 2, 2022 – Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug...

2022 Wells Fargo Healthcare Conference – Presentation

Events, News, Presentations

2022 Wells Fargo Healthcare Conference – Presentation Webcast...
« Older Entries
Next Entries »

Sutro Biopharma

111 Oyster Point Blvd
South San Francisco, CA 94080

Phone: 650-881-6500

Dedicated to patients
and changing the future of oncology

  • Follow
  • Follow
  • Follow
  • Follow

Follow us on social media

© 2026 Sutro Biopharma, Inc.
South San Francisco, California, U.S.A.

SITE MAP | PRIVACY POLICY  | EMAIL ALERTS | CONTACT US | VISITOR GUIDE

 

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Sutro Biopharma, Inc.
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.